Dr. reddy's initiates process for emergency use authorization of sputnik v

Hyderabad, india--(business wire)--dr. reddy's laboratories ltd. (bse: 500124, nse: drreddy, nyse: rdy, nseifsc: drreddy along with its subsidiaries together referred to as “dr. reddy's”) today announced that it has initiated the process with the drugs controller general of india (dcgi) for emergency use authorization (eua) of the well-studied human adenoviral vector-based platform vaccine candidate, sputnik v. as part of the review process, dr. reddy's will present the safety profile of the pha
RDY Ratings Summary
RDY Quant Ranking